about
Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer.Capecitabine/Cyclophosphamide/Methotrexate for patients with metastatic breast cancer: a dose-finding, feasibility, and efficacy study.Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer.New developments in the treatment of metastatic breast cancer: from chemotherapy to biological therapy.Adjuvant trastuzumab in early breast cancer.Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer.Metastatic breast cancer treated with lapatinib with a prolonged benefit: a case report and a review of therapeutic options available.Gene expression profiling of circulating tumor cells in breast cancer.Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning.¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot study.2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.Lapatinib and letrozole as first-line therapy for metastatic breast cancer: case report of bone metastasis 18 years later.Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).
P50
Q33340710-64FA73C5-EB78-4CA0-A063-D7638CB5BDB3Q33373205-A80436A7-C2AA-477C-8EF2-08C11415132FQ33433527-835B175E-D5A1-4043-8C72-DE90AFB9647EQ33989876-6D24E5CB-2847-4FA9-8702-688882B1FC71Q36164335-931E3136-7516-495C-AAC7-FE97CABEBFDFQ36612821-06254C89-F092-4595-8D11-92096E169C18Q37357924-8539FA08-32F4-4569-992B-38F88BA99477Q38185885-7473C958-F673-4272-95D2-D3BB5E0156C0Q38470332-7C9C39BC-63BA-4F78-99B6-CD2CF64C565BQ38835169-7F96A327-EA97-4500-BCF9-1E8A57962847Q51009203-05F3FAF2-E8AA-4C3A-B26E-C16EC0D1E613Q53243856-A2D7E1FA-CF7B-4724-94A2-777E5D9F5000Q54312359-B5D52CBE-3036-458E-B203-1196874B678EQ54391460-470D2532-ED79-455C-BCAF-FB116E868A1C
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gabriella Mariani
@ast
Gabriella Mariani
@en
Gabriella Mariani
@es
Gabriella Mariani
@nl
Gabriella Mariani
@sl
type
label
Gabriella Mariani
@ast
Gabriella Mariani
@en
Gabriella Mariani
@es
Gabriella Mariani
@nl
Gabriella Mariani
@sl
prefLabel
Gabriella Mariani
@ast
Gabriella Mariani
@en
Gabriella Mariani
@es
Gabriella Mariani
@nl
Gabriella Mariani
@sl
P1053
J-4223-2017
P106
P1153
7102512273
P21
P31
P3829
P496
0000-0001-7733-3143